Boston Scientific stock rallies 1.02% and outperforms peers
Updated
Updated · MarketWatch · May 7
Boston Scientific stock rallies 1.02% and outperforms peers
6 articles · Updated · MarketWatch · May 7
Shares closed at $56.57 on Thursday, their second straight gain, as the S&P 500 fell 0.38% and the Dow dropped 0.63%.
Boston Scientific beat rival moves from Abbott, Medtronic and Stryker, while trading volume reached 25.5 million shares, above its 50-day average of 16.3 million.
Despite the rise, the stock remains 48.34% below its 52-week high of $109.50 reached on 9 September.
Is Boston Scientific's rally a true recovery or just a dead cat bounce before its next major hurdle?
Will the massive Penumbra acquisition secure Boston Scientific's future or is it a risky gamble that could sink the company?